Breaking News

The company posted Q3 revenues of $10.6 million, up from $5.7 million in Q3 2017 and beating the consensus Wall Street estimate of $8.5 million.

The company reported its third-quarter results concomitantly with an announcement that Illumina plans to acquire the firm for approximately $1.2 billion.

Illumina touted PacBio's accuracy, technology roadmap, and potential clinical applications as key to why the company wanted to acquire it.

Revenues in the third quarter grew to $466.6 million from $335.6 million in Q3 2017, beating the consensus Wall Street estimate of $451.7 million.

The company said it saw the biggest revenue growth in its instruments business, which gained 32 percent year over year.

DefiniGen said it plans to use ERS Genomics' technology to create disease models to support drug discovery for type 2 diabetes and other conditions.

Using a mouse model of immunotherapy resistant disease, the researchers found that this program could be targeted by an inhibitor to improve response.

Hmong and Karen immigrants to the US quickly lost diversity in their microbiomes and experienced shifts in the microbes present in their guts.

With genome-wide association studies involving more than 200,000 individuals, researchers narrowed in on 58 loci and dozens of genes with ties to a chronic infection marker.

After six straight months of gains, the index saw a sharp drop in October that even positive earnings news could not stave off.

Precipio said that its ICE COLD-PCR reagents will be sold with PerkinElmer's DNA/RNA extraction and isolation products.

Researchers trained a machine-learning model to predict animal reservoirs or insect vectors for dozens of "orphan" viruses with unknown natural sources.

The agency informed the public that most PGx tests haven’t been reviewed by the agency, and they should refer to information in FDA approved product labels when using such tests.

Patients with rare protein-truncating variants tended to have aggressive tumors while those with a high polygenic risk score often had milder disease.

The program will be led by computational scientist Adam Margolin and focus on integrating large-scale data analysis and genomic technologies to speed drug discoveries.

The company offers kits and services based on a synthetic long-read sequencing technology that enables short-read sequencers to generate long-read data.

The Darwin Tree of Life Project aims to sequence the genetic codes of 66,000 different species in the UK as part of the Earth BioGenome Project.

The firm missed the Wall Street estimates on the top and bottom lines, and it lowered its EPS and adjusted EPS guidance for full-year 2018.

The market authorization came with a number of caveats and special requirements that 23andMe must follow when selling its PGx tests to consumers.

The new analysis also uncovered knowledge gaps about why people are worried about genetic privacy.

Researchers identified 133 neuronal and non-neuronal cell types using single-cell RNA-seq data for tens of thousands of cells from the mouse neocortex.

The fully automated system has 12 independent thermal cyclers and runs the firm's diagnostic kits, but it can also operate as an open instrument.

Dovetail offers genome assembly services for plant, animal, and microbial genomes based on its proprietary proximity ligation and sequencing protocol.

An analysis of matched tumor-normal samples from dozens of colorectal cancer patients pointed to microbiome differences related to mutations and other tumor features.

At AMP, the companies announced a partnership to add Paragon Genomics' NGS target enrichment technologies to the flagship Sophia AI platform worldwide.

Pages

Though many details have yet to be worked out, the draft deal for the UK's withdrawal from the EU is giving researchers some hints for what they can expect, Nature News says.

DNA testing has solved a 100-year-old mystery contained in the skull and teeth samples of a now-extinct monkey that once inhabited Jamaica, Gizmodo reports.

As the UN ponders a ban on gene drives, one malaria researcher says there are less dramatic ways to fight the disease in Africa than unleashing GM mosquitoes on a whole continent.

In Nature this week: an improved reference genome of the Aedes aegypti mosquito, genomes of four species of truffles, and more.